• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉毒杆菌毒素在运动障碍治疗中的应用经验

Experiences on The Administration of Botulinum Toxin in Movement Disorders.

作者信息

Tuğan Yıldız Buket, Tuncel Berktaş Deniz

机构信息

Kahramanmaraş Sütçü İmam University, School of Medicine, Department of Neurology, Kahramanmaraş, Turkey.

出版信息

J Transl Int Med. 2021 Jan 5;9(1):52-56. doi: 10.2478/jtim-2021-0003. eCollection 2021 Mar.

DOI:10.2478/jtim-2021-0003
PMID:33850802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8016350/
Abstract

BACKGROUND AND OBJECTIVES

Botulinum toxin injection has been used for many years for various indications such as cervical dystonia, blepharospasm, oromandibular dystonia, hemifacial spasm in neurology. Botulinum toxin injections have been made in our clinic for about ten years. We want to report our experiences about botulinum toxin treatment in neurologic disease.

METHODS

In this study, the data of the patients receiving BoNT injection between January 2018 and December 2019 was retrospectively analyzed. Age, gender, botulinum toxin indications, and mean dose, duration of efficacy, side effects noted for each injection were recorded.

RESULTS

There were 122 patients who received botulinum toxin injections between January 2018 and December 2019. Of the 122 patients identified, 28 had cervical dystonia, 61 had HFS, 21 had blepharospasm, 4 had generalized dystonia, 1 had hemidystonia following thalamic bleeding, 1 had tardive dystonia, 4 had migraine, 1 had bruxism and 1 had both migraine and bruxism.

CONCLUSION

BoNT injection is a treatment that has been used for various indications in neurology for almost 40 years. Side effects are limited and temporary with appropriate injections. We also had a wide range of indication profiles and high numbers of patients to whom we administered the BoNT treatment.

摘要

背景与目的

肉毒杆菌毒素注射多年来一直用于多种适应症,如神经科的颈部肌张力障碍、眼睑痉挛、口下颌肌张力障碍、偏侧面肌痉挛。在我们诊所进行肉毒杆菌毒素注射已有约十年时间。我们想报告我们在神经疾病肉毒杆菌毒素治疗方面的经验。

方法

在本研究中,对2018年1月至2019年12月期间接受肉毒杆菌毒素注射的患者数据进行回顾性分析。记录年龄、性别、肉毒杆菌毒素适应症、平均剂量、疗效持续时间以及每次注射所记录的副作用。

结果

2018年1月至2019年12月期间有122例患者接受了肉毒杆菌毒素注射。在这122例确诊患者中,28例患有颈部肌张力障碍,61例患有偏侧面肌痉挛,21例患有眼睑痉挛,4例患有全身性肌张力障碍,1例在丘脑出血后患有偏侧肌张力障碍,1例患有迟发性肌张力障碍,4例患有偏头痛,1例患有磨牙症,1例同时患有偏头痛和磨牙症。

结论

肉毒杆菌毒素注射是一种在神经科用于多种适应症近40年的治疗方法。通过适当注射,副作用有限且为暂时性。我们也有广泛的适应症范围以及大量接受肉毒杆菌毒素治疗的患者。

相似文献

1
Experiences on The Administration of Botulinum Toxin in Movement Disorders.肉毒杆菌毒素在运动障碍治疗中的应用经验
J Transl Int Med. 2021 Jan 5;9(1):52-56. doi: 10.2478/jtim-2021-0003. eCollection 2021 Mar.
2
[Botulinum toxin therapy for focal dystonia].[肉毒杆菌毒素治疗局灶性肌张力障碍]
Orv Hetil. 2009 Jul 19;150(29):1381-4. doi: 10.1556/OH.2009.28640.
3
Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.A型肉毒杆菌毒素注射治疗眼睑痉挛和半面痉挛的长期疗效及安全性。
Clin Exp Ophthalmol. 2014 Apr;42(3):254-61. doi: 10.1111/ceo.12165. Epub 2013 Aug 4.
4
Use of Alleviating Maneuvers for Periocular Facial Dystonias.缓解性手法在眼周面部肌张力障碍中的应用。
JAMA Ophthalmol. 2016 Nov 1;134(11):1247-1252. doi: 10.1001/jamaophthalmol.2016.3277.
5
Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.新加坡一家运动障碍诊所中用于治疗神经疾病的肉毒杆菌毒素
Singapore Med J. 1998 Sep;39(9):403-5.
6
A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.原发性面肌痉挛和眼睑痉挛的对比交叉研究:眶隔前和睑板前肉毒毒素注射技术。
Neurol Sci. 2017 Nov;38(11):2031-2036. doi: 10.1007/s10072-017-3107-2. Epub 2017 Sep 7.
7
Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.从肉毒杆菌素(Dysport)转换为保妥适(BOTOX)治疗眼睑痉挛、颈部肌张力障碍和半面痉挛后,保妥适的安全性、有效性及疗效持续时间。
Curr Med Res Opin. 2005 Mar;21(3):433-8. doi: 10.1185/030079905X36396.
8
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.循证综述与评估肉毒毒素治疗运动障碍。
Toxicon. 2013 Jun 1;67:94-114. doi: 10.1016/j.toxicon.2012.12.004. Epub 2013 Feb 4.
9
Real-world experience with botulinum toxin A for the treatment of hemifacial spasm: A study of 1138 injections.肉毒杆菌毒素A治疗面肌痉挛的真实世界经验:一项关于1138次注射的研究。
Clin Neurol Neurosurg. 2021 Jun;205:106632. doi: 10.1016/j.clineuro.2021.106632. Epub 2021 Apr 2.
10
Botulinum toxin A in blepharospasm and hemifacial spasm.肉毒杆菌毒素A治疗眼睑痉挛和半面痉挛。
J Assoc Physicians India. 1994 Mar;42(3):205-8.

引用本文的文献

1
The role of microRNAs in ferroptosis.微小RNA在铁死亡中的作用。
Front Mol Biosci. 2022 Oct 12;9:1003045. doi: 10.3389/fmolb.2022.1003045. eCollection 2022.
2
Time to onset and duration of botulinum toxin efficacy in movement disorders.运动障碍中肉毒毒素疗效的起效时间和持续时间。
J Neurol. 2022 Jul;269(7):3706-3712. doi: 10.1007/s00415-022-10995-2. Epub 2022 Feb 3.

本文引用的文献

1
Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia.在颈部肌张力障碍的实际临床管理中,阿柏西普肉毒素A与昂丹司琼肉毒素A的经济学评估
J Clin Mov Disord. 2020 Feb 11;7:2. doi: 10.1186/s40734-020-0083-0. eCollection 2020.
2
Clinical Features of Benign Essential Blepharospasm in Korean Patients.韩国患者良性原发性眼睑痉挛的临床特征
Korean J Ophthalmol. 2018 Oct;32(5):339-343. doi: 10.3341/kjo.2018.0038.
3
Clinical and genetic features of cervical dystonia in a large multicenter cohort.大样本多中心队列研究中痉挛性斜颈的临床和遗传学特征。
Neurol Genet. 2016 Apr 11;2(3):e69. doi: 10.1212/NXG.0000000000000069. eCollection 2016 Jun.
4
Hemifacial spasm: The past, present and future.面肌痉挛:过去、现在与未来。
J Neurol Sci. 2015 Sep 15;356(1-2):27-31. doi: 10.1016/j.jns.2015.06.032. Epub 2015 Jun 16.
5
Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).用于观察A型肉毒毒素疗效的颈部肌张力障碍患者登记研究(CD PROBE)的主要结果。
J Neurol Sci. 2015 Feb 15;349(1-2):84-93. doi: 10.1016/j.jns.2014.12.030. Epub 2014 Dec 27.
6
Clinical features and treatment with botulinum toxin in blepharospasm: a 17-year experience.睑痉挛的临床特征及肉毒杆菌毒素治疗:17年经验
Arq Neuropsiquiatr. 2012 Sep;70(9):662-6. doi: 10.1590/s0004-282x2012000900003.
7
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.肉毒杆菌毒素 A 治疗慢性偏头痛:来自 PREEMPT 2 试验双盲、随机、安慰剂对照阶段的结果。
Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17.
8
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.肉毒杆菌毒素 A 治疗慢性偏头痛:PREEMPT 1 试验双盲、随机、安慰剂对照阶段的结果。
Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17.
9
Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport.面肌痉挛和再神经支配联带运动:肉毒毒素或 Dysport 的长期治疗。
J Neural Transm (Vienna). 2010 Jun;117(6):759-63. doi: 10.1007/s00702-010-0409-4. Epub 2010 May 1.
10
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm.肉毒杆菌毒素和Dysport长期治疗半面痉挛的疗效、安全性及预后预测因素
Eur J Neurol. 2009 Mar;16(3):392-8. doi: 10.1111/j.1468-1331.2008.02507.x.